MOBILE PATH Trademark

Trademark Overview


On Friday, January 25, 2019, a trademark application was filed for MOBILE PATH with the United States Patent and Trademark Office. The USPTO has given the MOBILE PATH trademark a serial number of 88276625. The federal status of this trademark filing is REGISTERED as of Tuesday, September 27, 2022. This trademark is owned by Essenlix Corporation. The MOBILE PATH trademark is filed in the Chemical Products, Pharmaceutical Products, Medical Instrument Products, and Medical & Beauty Services & Agricultural Services categories with the following description:

Assays for research purposes; Biological and chemical reagents used for non-medical purposes, in vitro and in vivo scientific use, the testing of bodily fluids, and the detecting and analyzing of cells, proteins, small molecules, and nucleotides; Biological and chemical test kits for laboratory or research use in the field of personal wellness; Biological and chemical test kits for laboratory or research use for the detection and identification of nucleic acids, namely, DNA and RNA in a sample

Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, or abnormalities in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical apparatus, devices, and instruments for wellness testing, health condition testing, and healthcare testing, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovasc...

Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Healthcare services in the field of digital healthcare services; Diagnostic services, namely, medical testing for diagnostic purposes; Wellness services, namely, providing wellness information; Medical services, medical assistance, medical consultations, medical counseling, medical information, healthcare testing, diagnostic testing, and wellness services, all in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other tissue- based diagnostic testing, cytology, and cell-based testing; Medical testing services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample

Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cells, proteins, small molecules, nucleotides, and nucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic biomarker reagents for medical purposes
mobile path

General Information


Serial Number88276625
Word MarkMOBILE PATH
Filing DateFriday, January 25, 2019
Status700 - REGISTERED
Status DateTuesday, September 27, 2022
Registration Number6859760
Registration DateTuesday, September 27, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2019

Trademark Statements


Goods and ServicesAssays for research purposes; Biological and chemical reagents used for non-medical purposes, in vitro and in vivo scientific use, the testing of bodily fluids, and the detecting and analyzing of cells, proteins, small molecules, and nucleotides; Biological and chemical test kits for laboratory or research use in the field of personal wellness; Biological and chemical test kits for laboratory or research use for the detection and identification of nucleic acids, namely, DNA and RNA in a sample
Goods and ServicesMedical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, or abnormalities in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical apparatus, devices, and instruments for wellness testing, health condition testing, and healthcare testing, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical apparatus, devices, and instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample
NOT AVAILABLE"MOBILE"
Goods and ServicesMedical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Healthcare services in the field of digital healthcare services; Diagnostic services, namely, medical testing for diagnostic purposes; Wellness services, namely, providing wellness information; Medical services, medical assistance, medical consultations, medical counseling, medical information, healthcare testing, diagnostic testing, and wellness services, all in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other tissue- based diagnostic testing, cytology, and cell-based testing; Medical testing services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample
Goods and ServicesMedical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cells, proteins, small molecules, nucleotides, and nucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic biomarker reagents for medical purposes

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateSunday, February 17, 2019
Primary Code001
First Use Anywhere DateThursday, July 21, 2022
First Use In Commerce DateThursday, July 21, 2022

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, February 17, 2019
Primary Code005
First Use Anywhere DateThursday, July 21, 2022
First Use In Commerce DateThursday, July 21, 2022

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSunday, February 17, 2019
Primary Code010
First Use Anywhere DateThursday, July 21, 2022
First Use In Commerce DateThursday, July 21, 2022

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, February 17, 2019
Primary Code044
First Use Anywhere DateThursday, July 21, 2022
First Use In Commerce DateThursday, July 21, 2022

Trademark Owner History


Party NameEssenlix Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMonmouth Junction, NJ 08852
US

Party NameEssenlix Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMonmouth Junction, NJ 08852
US

Party NameEssenlix Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMonmouth Junction, NJ 08852
US

Trademark Events


Event DateEvent Description
Tuesday, January 29, 2019NEW APPLICATION ENTERED
Sunday, February 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 22, 2019ASSIGNED TO EXAMINER
Friday, March 22, 2019NON-FINAL ACTION WRITTEN
Friday, March 22, 2019NON-FINAL ACTION E-MAILED
Friday, March 22, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 18, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 25, 2019ASSIGNED TO LIE
Monday, September 30, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 30, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 18, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, October 18, 2019EXAMINERS AMENDMENT E-MAILED
Friday, October 18, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 18, 2019EXAMINER'S AMENDMENT ENTERED
Friday, October 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 26, 2019PUBLISHED FOR OPPOSITION
Tuesday, November 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 9, 2020SOU TEAS EXTENSION RECEIVED
Thursday, July 9, 2020SOU EXTENSION 1 FILED
Thursday, July 9, 2020SOU EXTENSION 1 GRANTED
Saturday, July 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 15, 2021SOU TEAS EXTENSION RECEIVED
Friday, January 15, 2021SOU EXTENSION 2 FILED
Friday, January 15, 2021SOU EXTENSION 2 GRANTED
Tuesday, January 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 21, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, July 21, 2021SOU EXTENSION 3 FILED
Wednesday, July 21, 2021SOU EXTENSION 3 GRANTED
Friday, July 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 20, 2022SOU TEAS EXTENSION RECEIVED
Thursday, January 20, 2022SOU EXTENSION 4 FILED
Thursday, January 20, 2022SOU EXTENSION 4 GRANTED
Saturday, January 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 21, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, August 9, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 21, 2022USE AMENDMENT FILED
Tuesday, August 9, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, August 19, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, August 20, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 27, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, September 27, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 3, 2026TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 3, 2026APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 3, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 3, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 3, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED